RVL Pharmaceuticals plc Quarterly Entity Common Stock, Shares Outstanding from Q3 2018 to Q2 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
RVL Pharmaceuticals plc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2018 to Q2 2023.
  • RVL Pharmaceuticals plc Entity Common Stock, Shares Outstanding for the quarter ending August 11, 2023 was 99.5M shares, a 0.39% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 99.5M +385K +0.39% Aug 11, 2023 10-Q 2023-08-14
Q1 2023 99.3M +15.8M +19% Mar 17, 2023 10-K 2023-03-20
Q3 2022 99.2M +15.9M +19.1% Nov 9, 2022 10-Q 2022-11-10
Q2 2022 99.1M +36.3M +57.7% Aug 10, 2022 10-Q 2022-08-11
Q1 2022 83.5M +20.8M +33.2% Mar 29, 2022 10-K 2022-03-30
Q3 2021 83.3M +20.7M +33.1% Nov 12, 2021 10-Q 2021-11-15
Q2 2021 62.9M -898K -1.41% Aug 13, 2021 10-Q 2021-08-16
Q1 2021 62.7M +3.82M +6.49% Mar 29, 2021 10-K 2021-03-30
Q3 2020 62.6M +10.7M +20.5% Nov 9, 2020 10-Q 2020-11-10
Q2 2020 63.8M +11.3M +21.4% Aug 10, 2020 10-Q 2020-08-11
Q1 2020 58.9M +6.38M +12.1% Mar 10, 2020 10-K 2020-03-19
Q3 2019 51.9M -593K -1.13% Nov 13, 2019 10-Q 2019-11-14
Q2 2019 52.5M Aug 7, 2019 10-Q 2019-08-08
Q1 2019 52.5M Mar 27, 2019 10-K 2019-03-28
Q3 2018 52.5M Nov 7, 2018 10-Q 2018-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.